Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

References for PMC Articles for PubMed (Select 17275887)

1.

Inflammation and the activated protein C anticoagulant pathway.

Esmon CT.

Semin Thromb Hemost. 2006 Apr;32 Suppl 1:49-60. Review.

PMID:
16673266
2.

The discovery of TAFI.

Nesheim M, Bajzar L.

J Thromb Haemost. 2005 Oct;3(10):2139-46. No abstract available.

PMID:
16194190
3.

U.K. Controlled trial of intrapleural streptokinase for pleural infection.

Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, Lane DJ, Darbyshire JH, Davies RJ; First Multicenter Intrapleural Sepsis Trial (MIST1) Group.

N Engl J Med. 2005 Mar 3;352(9):865-74. Erratum in: N Engl J Med. 2005 May 19;352(20):2146.

4.

The matrix unloaded: aerosolized heparin or urokinase for pulmonary fibrosis.

Idell S.

Am J Respir Crit Care Med. 2003 Dec 1;168(11):1268-9. No abstract available.

PMID:
14644921
5.

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.

Idell S.

Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. Review.

PMID:
12682443
6.

Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.

Idell S, Mazar A, Cines D, Kuo A, Parry G, Gawlak S, Juarez J, Koenig K, Azghani A, Hadden W, McLarty J, Miller E.

Am J Respir Crit Care Med. 2002 Oct 1;166(7):920-6.

PMID:
12359647
7.
8.

Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.

Katz BA, Mackman R, Luong C, Radika K, Martelli A, Sprengeler PA, Wang J, Chan H, Wong L.

Chem Biol. 2000 Apr;7(4):299-312.

9.

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Guex N, Peitsch MC.

Electrophoresis. 1997 Dec;18(15):2714-23.

PMID:
9504803
10.

Identification of a flexible loop region (297-313) of urokinase-type plasminogen activator, which helps determine its catalytic activity.

Sun Z, Jiang Y, Ma Z, Wu H, Liu BF, Xue Y, Tang W, Chen Y, Li C, Zhu D, Gurewich V, Liu JN.

J Biol Chem. 1997 Sep 19;272(38):23818-23. Erratum in: J Biol Chem 1998 Jan 9;273(2):1268. Zhong, M [corrected to Ma, Z]; Xu, Y [corrected to Xue, Y].

11.

Optimal subsite occupancy and design of a selective inhibitor of urokinase.

Ke SH, Coombs GS, Tachias K, Corey DR, Madison EL.

J Biol Chem. 1997 Aug 15;272(33):20456-62.

12.

A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.

Liu JN, Tang W, Sun ZY, Kung W, Pannell R, Sarmientos P, Gurewich V.

Biochemistry. 1996 Nov 12;35(45):14070-6.

PMID:
8916892
13.

A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.

Braat EA, Nauland U, Dooijewaard G, Rijken DC.

Thromb Haemost. 1996 Jun;75(6):908-14.

PMID:
8822585
14.

VMD: visual molecular dynamics.

Humphrey W, Dalke A, Schulten K.

J Mol Graph. 1996 Feb;14(1):33-8, 27-8.

PMID:
8744570
15.

The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.

Robbie LA, Booth NA, Croll AM, Bennett B.

Thromb Haemost. 1993 Aug 2;70(2):301-6.

PMID:
8236139
17.

Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation.

Menhart N, Hoover GJ, McCance SG, Castellino FJ.

Biochemistry. 1995 Feb 7;34(5):1482-8.

PMID:
7849007
18.

Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.

Strange C, Baumann MH, Sahn SA, Idell S.

Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):508-15.

PMID:
7842213
19.

Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.

Carr ME Jr, Alving BM.

Blood Coagul Fibrinolysis. 1995 Sep;6(6):567-73.

PMID:
7578900
20.

Regulation of fibrin deposition by malignant mesothelioma.

Idell S, Pueblitz S, Emri S, Gungen Y, Gray L, Kumar A, Holiday D, Koenig KB, Johnson AR.

Am J Pathol. 1995 Nov;147(5):1318-29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk